In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?-Reference-Cited by-同舟云学术

In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?

Published:2021-07-05 Issue:11 Volume:41 Page:1915-1924
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Yagiz Burcu^ORCID,Coskun Belkis Nihan^ORCID,Pehlivan Yavuz^ORCID,Dalkilic Ediz^ORCID,Kiraz Sedat^ORCID,Yazisiz Veli^ORCID,Kucuksahin Orhan^ORCID,Erden Abdulsamet^ORCID,Kanitez Nilufer Alpay^ORCID,Kimyon Gezmiş^ORCID,Emmungil Hakan^ORCID,Bilge Sule Yasar^ORCID,Kasifoglu Timucin^ORCID,Bes Cemal^ORCID,Bolek Ertugrul Cagri^ORCID,Bilgin Emre^ORCID,Karatas Ahmet^ORCID,Kelesoglu Bahar^ORCID,Ersozlu Duygu^ORCID,Gonullu Emel Orge^ORCID,Mercan Ridvan^ORCID,Yilmaz Sedat^ORCID,Karadag Omer^ORCID,Akar Servet^ORCID,Ertenli Ihsan^ORCID,Kalyoncu Umut^ORCID

Funder

Hacettepe Üniversitesi

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-021-04939-8.pdf

Reference24 articles.

1. Singh JA, Saag KG, Louis Bridges Jr S et al (2016) 2015 American college of rheumatology guidelines for the treatment of rheumatoid arthritis. Arthritis Care Res 68:1–25. https://doi.org/10.1002/acr.22783

2. Smolen JS, Landewé R, Bijlsma J et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76:960–977. https://doi.org/10.1136/annrheumdis-2016-210715

3. Tanaka Y (2013) Next stage of RA treatment: is TNF inhibitor-free remission a possible treatment goal? Ann Rheum Dis 72(Suppl 2):ii124–ii127. https://doi.org/10.1136/annrheumdis-2012-202350

4. Spivey CA, Griffith J, Kaplan C et al (2018) A Retrospective analysis of corticosteroid utilization before initiation of biologic DMARDs among patients with rheumatoid arthritis in the United States. Rheumatol Ther 5(1):255–270. https://doi.org/10.1007/s40744-017-0089-8

5. Gotzsche PC, Johansen HK (2005) Short-term low dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev 1:CD000189. https://doi.org/10.1002/14651858.CD000189.pub2

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China;Rheumatology International;2024-09-12

2. Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib;Scientific Reports;2023-09-20

3. Is it possible to discontinue glucocorticoids in rheumatoid arthritis with the use of synthetic disease-modifying antirheumatic drugs?;Zaporozhye Medical Journal;2023-07-20